A RANDOMIZED COMPARISON OF NOBORI BIOLIMUS A9 ELUTING STENT WITH CYPHER SIROLIMUS ELUTING STENT FOR CORONARY REVASCULARIZATION IN JAPANESE POPULATION
نویسندگان
چکیده
منابع مشابه
Randomized Comparison of the Nobori Biolimus A9-Eluting Coronary Stent With the Taxus Liberté Paclitaxel-Eluting Coronary Stent in Patients With Stenosis in Native Coronary Arteries
Bernard Chevalier, MD; Sigmund Silber, MD; Seung-Jung Park, MD, PhD; Eulogio Garcia, MD; Gerhard Schuler, MD, PhD; Harry Suryapranata, MD, PhD; Jacques Koolen, MD, PhD; Karl E. Hauptmann, MD; William Wijns, MD, PhD; Marie-Claude Morice, MD; Didier Carrie, MD, PhD; Gerrit-Anne van Es, PhD; Hirofumi Nagai, PhD; Danny Detiege, MS; Dragica Paunovic, MD; Patrick W. Serruys, MD, PhD; for the NOBORI 1...
متن کاملRandomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial.
BACKGROUND Outcomes after percutaneous coronary interventions in diabetic patients are shadowed by the increased rate of recurrence compared with nondiabetic patients. METHODS AND RESULTS We conducted a multicenter, randomized trial to demonstrate the efficacy of sirolimus-eluting stents compared with standard stents to prevent restenosis in diabetic patients with de novo lesions in native co...
متن کاملComparison of zotarolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for coronary revascularization: the ZEST (comparison of the efficacy and safety of zotarolimus-eluting stent with sirolimus-eluting and paclitaxel-eluting stent for coronary lesions) randomized trial.
OBJECTIVES The aim of this study was to evaluate the relative efficacy and safety of zotarolimus-eluting stents (ZES) in comparison with the established and widely used sirolimus- (SES) and paclitaxel-eluting stents (PES) in routine clinical practice. BACKGROUND Whether ZES might provide similar clinical and angiographic outcomes in a broad spectrum of patients compared with SES or PES is und...
متن کاملRandomized Comparison of a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent With a Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention
In percutaneous coronary interventions, drug-eluting stents (DESs) have reduced the risk of restenosis and repeat revascularization compared with bare-metal stents. The secondgeneration DESs with thinner stent struts have improved safety and efficacy compared with the first-generation DESs and has been associated with a reduced risk of late stent thrombosis. The persistence of polymer material ...
متن کاملClinical outcomes of patients treated with Nobori biolimus-eluting stent: Meta-analysis of randomized trials.
BACKGROUNDS The Nobori is a new-generation, biodegradable-polymer coated, biolimus-eluting stent (BES) that has recently been investigated in several randomized trials with inconsistent results. The aim of this study was to assess the efficacy and safety of Nobori BES versus other drug-eluting stents (DES) in patients treated with percutaneous coronary intervention (PCI). METHODS We undertook...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 2010
ISSN: 0735-1097
DOI: 10.1016/s0735-1097(10)61801-3